
MDI launches healthcare fund with Indonesian strategic

MDI Ventures, the corporate VC arm of state-controlled Telkom Indonesia, has launched a USD 20m fund with domestic vaccine manufacturer Bio Farma that will pursue early and growth-stage healthcare investments.
State-owned Bio Farma will serve as LP and provide the entire corpus. It will also provide strategic support to portfolio companies, leveraging its resources to act as a go-to-market channel. To this end, the fund is not limited to investments in Indonesia; it may back global start-ups where there is a domestic application opportunity.
Honesti Basyir, president director of Bio Farma, said the goal is to increase the company’s capabilities in life sciences and healthcare technology with a view to forming a national health ecosystem.
“Bio Farma, as the parent company of state-owned pharmaceutical enterprises, will add to its portfolio more than vaccines and serums, as during the COVID-19 pandemic we’ve innovated to produce diagnostic kits such as mBio-Cov and Biosaliva,” he added in a statement. “This was the result of collaboration with start-ups.”
Healthcare forms part of the remit for MDI’s core venture funds, the second of which closed on USD 500m in 2020. Telkom is the sole LP. The Bio-Health Fund may also capture opportunities identified under that strategy, co-investing in companies and offering strategic input via Bio Farma.
Pahala Nugraha Mansury, Indonesia’s vice minister of state-owned enterprises, noted that other companies should be looking to partner with MDI to gain access to technology and accelerate the development of their sectors. He called on Perkebunan Nusantara (PTPN), ID Food, and Perhutani in food and Pertamina in energy to pursue similar initiatives.
MDI Ventures claims five strategies – an accelerator plus four funds – that span the entire start-up journey. Some of these funds are collaborative efforts with third parties. For example, Arise is a seed investment unit established with financial technology specialist Finch Capital and Centauri Fund was launched with Korea’s KB Investments to participate in Series A and B rounds.
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.